PCOS hair loss: what helps and when to seek advice

Women experiencing hair thinning alongside polycystic ovary syndrome (PCOS), a condition affecting hormones and ovarian function, have treatment options, but not every approach has equally strong evidence. A Healthline guide brings together medicines, supplements and cosmetic support, highlighting a distinction: treating the underlying hormonal condition and encouraging scalp hair growth are not necessarily the same thing.

For UK readers, another distinction matters. The guide describes US medicines regulation and costs, which do not establish what is licensed, suitable or available through the NHS. Treatment decisions also depend on the pattern of hair loss, other symptoms and pregnancy plans.

What happened

Healthline’s overview describes how PCOS can be associated with female pattern hair loss, a gradual reduction in scalp hair density. It discusses both medicines applied to the scalp and prescriptions that reduce androgen activity. Androgens are hormones, including testosterone, that occur naturally in women as well as men.

This is treatment guidance rather than a report of a new clinical trial. Its recommendations draw on different types of evidence, including research on female pattern hair loss generally and smaller studies of supplements. Those findings should not be treated as interchangeable proof of effectiveness specifically in women with PCOS.

Establishing what is causing the thinning

A PCOS diagnosis does not rule out other explanations for shedding. Iron deficiency, thyroid disease, recent illness and some medicines can affect hair. More than one cause can be present, so an assessment should consider when the change began and whether it is gradual, sudden, diffuse or patchy.

A GP may examine the scalp, review medicines and ask about periods, diet and recent health changes. Blood tests may be appropriate depending on that history. Hair thinning alone does not establish a PCOS diagnosis, and a hormone result cannot, by itself, explain every change in hair density.

Gradual thinning around the central parting and crown is more consistent with female pattern loss than a suddenly appearing bare patch. Our guide to female pattern baldness, its signs and treatment options explains this pattern. Pain, marked redness, scaling or an unusually smooth, shiny area warrants medical review because other scalp conditions require different care.

The background

Hair follicles, the structures in the skin that produce hairs, respond differently to hormones depending on their location. Increased androgen activity can encourage thicker facial or body hair while contributing to finer scalp hair. This helps explain why apparently opposite changes can happen in the same person.

In female pattern hair loss, affected follicles gradually produce shorter, finer hairs. This process is called miniaturisation. The scalp may become more visible even without dramatic handfuls of hair appearing in the shower. Genetic susceptibility also matters, and not everyone with PCOS develops scalp thinning.

Raised androgen levels are not found in every woman with female pattern loss. Follicles’ sensitivity to hormones can be relevant too. This is why treatment is guided by the overall clinical picture rather than an assumption that everyone needs the same hormone-blocking medicine.

Pattern thinning is different from temporary shedding

Telogen effluvium is increased shedding after more hairs than usual enter the resting stage of their growth cycle. It can follow illness, childbirth, substantial dietary restriction or other physical stresses. Unlike progressive miniaturisation, this form of shedding often improves after its trigger has resolved.

The timing can be misleading because shedding may begin months after the triggering event. Our explanation of postpartum hair loss and when to seek advice explores that delay. A woman with PCOS can also experience postpartum shedding, so the existing diagnosis should not automatically determine the explanation.

Medicine-related shedding is another possibility to discuss, without stopping a prescribed treatment independently. Our coverage of isotretinoin and hair loss describes one example. A medication review can help establish whether the timing fits and whether another explanation is more likely.